CEO pay for prescription videogame startup increased 124% last year


The CEO of the first company to receive an FDA approval for a therapeutic video game saw his compensation rise 124% last year, even as the company planned layoffs.

Previous Dewpoint inks another Big Pharma partnership to the tune of $745M
Next Whataburger expands footprint in Florida